Content about Diabetes mellitus

WAUKESHA, Wis. — Hamacher Resource Group on Tuesday announced it will present “Marketing Diabetes in the Retail Setting” June 21 at the Marketing Diabetes Prevention and Awareness Conference in Atlanta.

Dave Wendland, VP and part of the owners group at HRG, will share ideas about how retail pharmacies can collaborate with suppliers to bring innovation to the diabetes care category to better serve patients, capture incremental sales and significantly grow the category’s reach.

NEW YORK — Novo Nordisk and the Juvenile Diabetes Research Foundation on Wednesday announced the creation of a joint research and development team to discover and develop novel immunotherapies to prevent, treat and help cure Type 1 diabetes.

PHILADELPHIA — One-quarter of Type 2 diabetes patients do not take basal insulin as prescribed, while more than one-third suffer from hypoglycemia, according to a global survey funded by Novo Nordisk.

PHILADELPHIA — An investigational insulin being developed by Novo Nordisk significantly reduced the rate of hypoglycemia at night in adults with Type 2 diabetes, according to results of a late-stage clinical trial presented at the 72nd Scientific Sessions of the American Diabetes Association.

HOUSTON — Novo Nordisk is starting an organization in Houston designed to provide assistance to local diabetes education programs, the Danish drug maker said Tuesday.

The company announced that it was accepting applications from local organizations for funding from Novo Nordisk Community Care Houston, one of more than 20 Novo Nordisk Community Care programs started in 2011 that provide funding to local groups. The drug maker is investing $80,000 on the Houston initiative.

RARITAN, N.J. — A Johnson & Johnson subsidiary is seeking approval for a Type 2 diabetes treatment.

Janssen Research and Development has submitted a new drug application to the Food and Drug Administration for the approval of canagliflozin — an investigational oral, once-daily, selective sodium glucose co-transporter 2 inhibitor — for use in adult patients. Canagliflozin blocks the reabsorption of glucose by the kidney, increasing glucose excretion and lowering blood glucose levels, the company said.

RIDGEFIELD, Conn. — A drug used to treat Type 2 diabetes produced significant reduction in blood sugar in African-American patients, according to results of a late-stage clinical trial.

Boehringer Ingelheim Pharmaceuticals and Eli Lilly announced Thursday results of a phase-3 trial of Tradjenta (linagliptin) in which 226 patients with Type 2 diabetes received 5 mg of the drug once per day or placebo.

FRANKLIN LAKES, N.J. — Medical supply manufacturer BD has released a syringe with a shorter needle designed to reduce discomfort in patients with diabetes who must inject insulin, the company said Tuesday.

BD announced the introduction of the ultra-fine 6mm needle, saying more than 80% of patients expressed a preference for it in trials, and a recent article published by the American Association of Diabetes Educators recognized the safety and efficacy of shorter needles.

The needle is designed to deliver insulin subcutaneously in adults and children.

NEW YORK — Being overweight and obesity during adolescence are associated with an increased risk for cardiovascular disease risk factors, especially prediabetes and diabetes, according to researchers.

Medication nonadherence costs the U.S. healthcare system about $290 billion per year, according to New England Healthcare Institute. That big and scary number — the kind whose sheer enormity can make one’s eyes glaze over — is now even bigger.


ALEXANDRIA, Va. — The National Association of Chain Drug Stores announced on Wednesday that it has submitted comments to the U.S. House Ways and Means Subcommittee on Health urging that retail pharmacies remain exempt from the Medicare durable medical equipment competitive bidding program. The subcommittee held a hearing regarding the program on Wednesday.

WOONSOCKET, R.I. — CVS/pharmacy took center stage on the latest episode of "The Doctors," as one of the chain's pharmacists sat down with one of the show's co-hosts to discuss how patients can manage diabetes on a budget.

Speaking with emergency room physician Dr. Travis Stork, CVS pharmacist Usheema Thomas told an audience member that recently was diagnosed with diabetes how to manage her condition by using a blood-glucose monitoring system. Thomas also discussed CVS/pharmacy's free ExtraCare for Diabetes program and the benefits of enrolling into the program.